$50.9 Million is the total value of Blackcrane Capital, LLC's 12 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AXNX | Sell | AXONICS MODULATION TECHNOLOG | $6,227,000 | -2.2% | 124,736 | -0.0% | 12.23% | -17.7% |
RCEL | Sell | AVITA THERAPEUTICS INCsponsored ads | $5,732,000 | -52.0% | 308,504 | -35.0% | 11.25% | -59.6% |
BHVN | Sell | BIOHAVEN PHARMACEUTICAL HOLD | $2,198,000 | -23.4% | 25,641 | -41.9% | 4.32% | -35.5% |
MSFT | Sell | MICROSOFT CORP | $1,013,000 | -18.4% | 4,555 | -22.8% | 1.99% | -31.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 14 | Q4 2021 | 20.2% |
NICE LTD - SPON ADR | 13 | Q1 2022 | 18.1% |
TAKEDA PHARMACEUTIC-SP ADR | 13 | Q1 2022 | 19.3% |
WIX.COM LTD | 10 | Q1 2022 | 24.7% |
PROFOUND MEDICAL CORP | 9 | Q1 2022 | 15.6% |
AXONICS MODULATION TECHNOLOG | 9 | Q4 2021 | 17.4% |
AVITA THERAPEUTICS INC | 8 | Q1 2022 | 31.8% |
BIOHAVEN PHARMACEUTICAL HOLD | 6 | Q4 2020 | 14.9% |
VISA INC-CLASS A SHARES | 5 | Q1 2020 | 14.9% |
HDFC BANK LTD-ADR | 5 | Q1 2022 | 21.7% |
View Blackcrane Capital, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2022-05-12 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-12 |
13F-HR | 2021-05-13 |
13F-HR | 2021-02-10 |
13F-HR | 2020-11-12 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-12 |
View Blackcrane Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.